MBX BIOSCIENCES INC (MBX)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About MBX BIOSCIENCES INC
MBX Biosciences, Inc. is a clinical-stage biotechnology company listed on the NASDAQ as MBX that develops precise peptide-based therapies for endocrine and metabolic conditions. Its work centers on peptide drug candidates aimed at hormone and metabolic disorders rather than marketed products, placing the company in the biopharmaceutical development phase.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
MBX BIOSCIENCES INC's Technical Indicators Summary
MBX is rated Strong Buy at 66.15, driven by a clear uptrend and constructive momentum. ADX near 36 signals a robust directional move while short- and medium-term averages sit well above the 200-day, indicating broad bullish alignment. Momentum readings and a supportive MACD back the advance, even as RSI remains in neutral-to-positive territory. Volatility is elevated with ATR around 4.51 and OBV shows recent distribution that tempers enthusiasm. The classic pivot lies just above the current price. Technical takeaway: Strong Buy — trend and moving averages favor bulls, though elevated volatility warrants caution.
| Indicator | Value |
|---|---|
RSI (14) | 58.87 |
Stochastic %K (14, 3, 3) | 63.57 |
CCI (20) | 73.71 |
WPR (14) | -42.12 |
Momentum (10) | 4.85 |
MFI | 61.98 |
MACD Level (12, 26) | 3.98 |
Bollinger Bands | $55.66 - $70.76 |
ATR (14) | $4.51 (6.82%) |
ADX (14) | 35.69 |
OBV | 45,820,437 |
Classic Pivot Point | $67.69 |
Fibonacci Pivot Point | $67.69 |
Simple Moving Averages | $36.55 - $66.01(5 indicators) |
Exponential Moving Averages | $37.59 - $65.90(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The last session brought a restrained decline for MBX, which slipped -2.46% to 66.15.
Trading Volume
Below 10d avg (527.9K)
310.4K
vs S&P 500 Today
Underperforming Market
-2.40%
52-Week Position
Upper range
89.7%
Updated: August 11, 2026 at 12:51 UTC